Evolus Inc (EOLS)

Evolus Inc (EOLS) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $472M; returns 1 day -5.4%, 1 week -1.3%, 1 year +3.9%.

Evolus Inc. is a global performance beauty company primarily focused on developing and commercializing aesthetic injectable products for the self-pay market. Its flagship product is Jeuveau® (prabotulinumtoxinA-xvfs), a proprietary neurotoxin indicated for the temporary improvement of moderate to severe glabellar lines (frown lines) in adults. Outside the U.S., Jeuveau is marketed as Nuceiva®.

Groups EOLS belongs to

• Healthcare
• Medical Devices
• Beauty Products
• Consumer Driven Elective Procedures
• Personal Care
• Biotechnology
• Commercial Stage
• Dermatology

EOLS financial model: income statement, cash flow and balance sheet